Investors

People are different and so is their cancer, patients should be treated individually.

Financial calendar

Date Report
24/11 2022 Interim Report Q3 2022
23/02 2023 Year-End Report 2022
25/05 2023 Interim Report Q1 2023
25/05 2023 Annual General Meeting
24/08 2023 Interim Report Q2 2023
23/11 2023 Interim Report Q3 2023

 

Upcoming events

February 23, 2023

Year-End Report 2022 released

View previous reports

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.